Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors

   
   

The present invention provides novel compounds that are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2 and analogues thereof and pharmaceutical compositions and kits that include these compounds.

 
Web www.patentalert.com

< Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases

< Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

> Treatment of conditions through pharmacological modulation of the autonomic nervous system

> Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase

~ 00191